Osteoporosis in Chronic Liver Disease
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Osteoporosis is a common skeletal complication seen in patients with chronic liver disease. Osteoporosis is usually asymptomatic and, if untreated, can result in fractures and impaired quality of life. For this review, we performed a systematic search of the PubMed database, and all recent peer‐reviewed articles regarding the prevalence, pathophysiology, diagnosis, and management of osteoporosis in chronic liver disease were included. The prevalence of osteoporosis varies between 11% and 58% in patients with chronic liver disease and in transplant recipients. The etiology of osteoporosis is multifactorial and only partially understood. Various factors linked to the pathogenesis of bone loss are vitamin D, calcium, insulin growth factor–1, receptor activation of nuclear factor–κB ligand (RANKL), bilirubin, fibronectin, leptin, proinflammatory cytokines, and genetic polymorphisms. Management of osteoporosis involves early diagnosis, identifying and minimizing risk factors, general supportive care, nutrition therapy, and pharmacotherapy. Osteoporosis is diagnosed based on the bone mineral density (BMD) assessment using dual‐energy X‐ray absorptiometry scan. Measurement of BMD should be considered in all patients with advanced liver disease and in transplant recipients. Vitamin D and calcium supplementation is recommended for all patients with osteoporosis. Specific agents used for treatment of osteoporosis include bisphosphonates, calcitonin, hormonal therapy, and raloxifene. Bisphosphonates have become the mainstay of therapy for osteoporosis prevention and treatment. Prolonged suppression of bone remodeling resulting in atypical fractures has emerged as a significant complication with long‐term use of bisphosphonates. Newer treatment agents and better fracture prevention strategies are necessary to prevent and treat osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Circulating levels of IGF-1 directly regulate bone growth and density
Yakar, S., Rosen, C. J., Beamer, W. G., Ackert-Bicknell, C. L., Wu, Y., Liu, J.-L., Ooi, G. T., Setser, J., Frystyk, J., Boisclair, Y. R., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215463 · Cited by 739
Eastell, R., Dickson, R. E., Hodgson, S. F., Wiesner, R. H., Porayko, M. K., Wahner, H. W., Cedel, S. L., Riggs, L. B., & Krom, R. A. F. (1991) · Hepatology · doi:10.1002/hep.1840140215 · Cited by 297
Gallego-Rojo, F. J., Gonzalez-Calvin, J. L., Muñoz-Torres, M., Mundi, J. L., Fernandez-Perez, R., & Rodrigo-Moreno, D. (1998) · Hepatology · doi:10.1002/hep.510280315 · Cited by 241
Guidelines on the management of osteoporosis associated with chronic liver disease
Collier, J. D., Ninkovic, M., & Compston, J. E. (2002) · Gut · doi:10.1136/gut.50.suppl_1.i1 · Cited by 241
Bone disorders in chronic liver disease
Collier, J. (2007) · Hepatology · doi:10.1002/hep.21852 · Cited by 238
Bone disease in primary biliary cirrhosis: independent indicators and rate of progression
Menon, K. V. N., Angulo, P., Weston, S., Dickson, E. R., & Lindor, K. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00144-1 · Cited by 180
Guañabens, N., Parés, A., Ros, I., Caballería, L., Pons, F., Vidal, S., Monegal, A., Peris, P., & Rodés, J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.035 · Cited by 179
Schiefke, I. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1843 · Cited by 156
Zein, C. O., Jorgensen, R. A., Clarke, B., Wenger, D. E., Keach, J. C., Angulo, P., & Lindor, K. D. (2005) · Hepatology · doi:10.1002/hep.20866 · Cited by 142
Guañabens, N., Cerdá, D., Monegal, A., Pons, F., Caballería, L., Peris, P., & Parés, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.016 · Cited by 142
Bone disease in patients with primary sclerosing cholangitis
Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K. D., Bjornsson, E., & Koch, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.014 · Cited by 133
Ninkovic, M., Love, S. A., Tom, B., Alexander, G. J. M., & Compston, J. E. (2001) · Calcified Tissue International · doi:10.1007/s00223-001-2028-4 · Cited by 123
Guichelaar, M. M. J., Schmoll, J., Malinchoc, M., & Hay, E. J. (2007) · Hepatology · doi:10.1002/hep.21805 · Cited by 120
Gonzalez-Calvin, J. L., Gallego-Rojo, F., Fernandez-Perez, R., Casado-Caballero, F., Ruiz-Escolano, E., & Olivares, E. G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0077 · Cited by 81
Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease
GARCÍA-VALDECASAS-CAMPELO, E., GONZÁLEZ-REIMERS, E., SANTOLARIA-FERNÁNDEZ, F., DE LA VEGA-PRIETO, M. J., MILENA-ABRIL, A., SÁNCHEZ-PÉREZ, M. J., MARTÍNEZ-RIERA, A., & GÓMEZ-RODRÍGUEZ, M. D. L. Á. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl004 · Cited by 77
Ruiz-Gaspà, S., Martinez-Ferrer, A., Guañabens, N., Dubreuil, M., Peris, P., Enjuanes, A., de Osaba, M. J. M., Alvarez, L., Monegal, A., Combalia, A., et al. (2010) · Hepatology · doi:10.1002/hep.24605 · Cited by 75
Osteoporosis in liver diseases and after liver transplantation
Hay, J. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00143-0 · Cited by 72
Levy, C., Harnois, D. M., Angulo, P., Jorgensen, R., & Lindor, K. D. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01026.x · Cited by 62
Misof, B. M., Bodingbauer, M., Roschger, P., Wekerle, T., Pakrah, B., Haas, M., Kainz, A., Oberbauer, R., Mühlbacher, F., & Klaushofer, K. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9161-2 · Cited by 41
Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease
Yurci, A., Kalkan, A. O., Ozbakir, O., Karaman, A., Torun, E., Kula, M., Baskol, M., Gursoy, S., Yucesoy, M., & Bayram, F. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834cd6f6 · Cited by 22
Cited by
Shen, G. S., Yang, Q., Jian, J. L., Zhao, G. Y., Liu, L. L., Wang, X., Zhang, W., Huang, X., & Xu, Y. J. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9845-8 · Cited by 51
Kim, G., Kim, K. J., Rhee, Y., & Lim, S.-K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182202 · Cited by 38
Bone disease and liver transplantation: a review
Rodríguez-Aguilar, E. F., Pérez-Escobar, J., Sánchez Herrera, D., García-Alanis, M., Toapanta-Yanchapaxi, L., Gonzalez-Flores, E., & García-Juárez, I. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.07.049 · Cited by 19
Risk factors for fractures following liver transplantation: a population-based cohort study
Chang, J.-W., Yang, H.-H., Lin, N.-C., Kuo, F.-C., Lin, T.-C., & Tsai, H.-L. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2230871 · Cited by 9
Metadata
- Authors
- Yadav, A., & Carey, E. J.
- Venue
- Nutrition in Clinical Practice
- Publisher
- Wiley
- Published
- 2012-12-20
- Volume
- 28
- Issue
- 1
- Pages
- 52-64
- ISSN
- 0884-5336 (ISSN-L)
- 1941-2452
- OpenAlex
- W2158245729
- Cited by
- 38
- References
- 20
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.